Human Genome Epidemiology Literature Finder
Records 1 - 9 (of 9 Records) |
Query Trace: Cholangiocarcinoma and IDH2[original query] |
---|
Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping. The oncologist 2012 17 (1): 72-9. Borger Darrell R, Tanabe Kenneth K, Fan Kenneth C, Lopez Hector U, Fantin Valeria R, Straley Kimberly S, Schenkein David P, Hezel Aram F, Ancukiewicz Marek, Liebman Hannah M, Kwak Eunice L, Clark Jeffrey W, Ryan David P, Deshpande Vikram, Dias-Santagata Dora, Ellisen Leif W, Zhu Andrew X, Iafrate A Jo |
Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas. Oncogene 2013 Jun 32 (25): 3091-100. Wang P, Dong Q, Zhang C, Kuan P-F, Liu Y, Jeck W R, Andersen J B, Jiang W, Savich G L, Tan T-X, Auman J T, Hoskins J M, Misher A D, Moser C D, Yourstone S M, Kim J W, Cibulskis K, Getz G, Hunt H V, Thorgeirsson S S, Roberts L R, Ye D, Guan K-L, Xiong Y, Qin L-X, Chiang D |
Genomic profiling of intrahepatic cholangiocarcinoma: refining prognosis and identifying therapeutic targets. Annals of surgical oncology 2014 Nov 21 (12): 3827-34. Zhu Andrew X, Borger Darrell R, Kim Yuhree, Cosgrove David, Ejaz Aslam, Alexandrescu Sorin, Groeschl Ryan Thomas, Deshpande Vikram, Lindberg James M, Ferrone Cristina, Sempoux Christine, Yau Thomas, Poon Ronnie, Popescu Irinel, Bauer Todd W, Gamblin T Clark, Gigot Jean Francois, Anders Robert A, Pawlik Timothy |
Circulating oncometabolite 2-hydroxyglutarate is a potential surrogate biomarker in patients with isocitrate dehydrogenase-mutant intrahepatic cholangiocarcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 2014 Apr 20 (7): 1884-90. Borger Darrell R, Goyal Lipika, Yau Thomas, Poon Ronnie T, Ancukiewicz Marek, Deshpande Vikram, Christiani David C, Liebman Hannah M, Yang Hua, Kim Hyeryun, Yen Katharine, Faris Jason E, Iafrate A John, Kwak Eunice L, Clark Jeffrey W, Allen Jill N, Blaszkowsky Lawrence S, Murphy Janet E, Saha Supriya K, Hong Theodore S, Wo Jennifer Y, Ferrone Cristina R, Tanabe Kenneth K, Bardeesy Nabeel, Straley Kimberly S, Agresta Sam, Schenkein David P, Ellisen Leif W, Ryan David P, Zhu Andrew |
Prognosis and Clinicopathologic Features of Patients With Advanced Stage Isocitrate Dehydrogenase (IDH) Mutant and IDH Wild-Type Intrahepatic Cholangiocarcinoma. The oncologist 2015 Sep 20 (9): 1019-27. Goyal Lipika, Govindan Aparna, Sheth Rahul A, Nardi Valentina, Blaszkowsky Lawrence S, Faris Jason E, Clark Jeffrey W, Ryan David P, Kwak Eunice L, Allen Jill N, Murphy Janet E, Saha Supriya K, Hong Theodore S, Wo Jennifer Y, Ferrone Cristina R, Tanabe Kenneth K, Chong Dawn Q, Deshpande Vikram, Borger Darrell R, Iafrate A John, Bardeesy Nabeel, Zheng Hui, Zhu Andrew |
Clinicopathological, radiologic, and molecular study of 23 combined hepatocellular-cholangiocarcinomas with stem cell features, cholangiolocellular type. Human pathology 2017 Apr . Chen Jun, He Jian, Deng Min, Wu Hong-Yan, Shi Jiong, Mao Liang, Sun Qi, Tang Min, Fan Xiang-Shan, Qiu Yu-Dong, Huang Q |
Crossing borders: A systematic review with quantitative analysis of genetic mutations of carcinomas of the biliary tract. Critical reviews in oncology/hematology 2019 6 140 8-16. Roos E, Soer E C, Klompmaker S, Meijer L L, Besselink M G, Giovannetti E, Heger M, Kazemier G, Klümpen H J, Takkenberg R B, Wilmink H, Würdinger T, Dijk F, van Gulik T M, Verheij J, van de Vijver M |
Association of TP53 Alteration with Tissue Specificity and Patient Outcome of IDH1-Mutant Glioma. Cells 2021 8 10 (8): . Murnyak Balazs, Huang L Er |
Circulating Cell-Free DNA-Based Comprehensive Molecular Analysis of Biliary Tract Cancers Using Next-Generation Sequencing. Cancers 2022 1 14 (1): . Csoma Szilvia Lilla, Bedekovics Judit, Veres Gerg?, Árokszállási Anita, András Csilla, Méhes Gábor, Mokánszki Atti |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: